Natural Killer Cell Therapies Market Report

Global and China Natural Killer Cell Therapies Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 29, 2022
  • PAGES：159
  • REPORT CODE：GMM1418911
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Natural Killer Cell Therapies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Kiadis Pharma

    • Nektar Therapeutics

    • NantWorks

    • Dragonfly Therapeutics

    • Fate Therapeutics

    • Glycostem

    • Chipscreen Biosciences

    • Innate

    • Fortress Biotech

    • Nkarta Therapeutics

    • Affimed

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • NK Cell Therapies

    • NK Cell Directed Antibodies

    Application:

    • Cancer

    • Gastrointestinal Diseases

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Natural Killer Cell Therapies Industry Overview

      • 1.1.1 Natural Killer Cell Therapies Market Scope and Market Segments

      • 1.1.2 Natural Killer Cell Therapies Industry Characteristics

      • 1.1.3 Global and China Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Natural Killer Cell Therapies Production Value and Growth Rate (2017-2028)

    • 1.2 Global Natural Killer Cell Therapies Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 NK Cell Therapies

      • 1.2.2 NK Cell Directed Antibodies

    • 1.3 Global Natural Killer Cell Therapies Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cancer

      • 1.3.2 Gastrointestinal Diseases

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Natural Killer Cell Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Natural Killer Cell Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Natural Killer Cell Therapies Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Natural Killer Cell Therapies Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Natural Killer Cell Therapies Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Natural Killer Cell Therapies Industry Porter's Five Forces Model Analysis

      • 2.2.3 Natural Killer Cell Therapies Industry PEST Analysis

    • 2.3 Natural Killer Cell Therapies Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Natural Killer Cell Therapies Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Natural Killer Cell Therapies Industry

    Chapter 3 Global and China Natural Killer Cell Therapies Market, by Manufacturer

    • 3.1 Global and China Natural Killer Cell Therapies Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Natural Killer Cell Therapies Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Natural Killer Cell Therapies Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Natural Killer Cell Therapies Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Natural Killer Cell Therapies Market Top 3 Players

    Chapter 4 Global and China Natural Killer Cell Therapies Market, by Type (2017-2028)

    • 4.1 Natural Killer Cell Therapies Market Trend, by Type

    • 4.2 Global Natural Killer Cell Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Natural Killer Cell Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Natural Killer Cell Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Natural Killer Cell Therapies Price Trend, by Type (2017-2028)

    • 4.3 China Natural Killer Cell Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Natural Killer Cell Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Natural Killer Cell Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Natural Killer Cell Therapies Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Natural Killer Cell Therapies Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Natural Killer Cell Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Natural Killer Cell Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Natural Killer Cell Therapies Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Natural Killer Cell Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Natural Killer Cell Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Natural Killer Cell Therapies Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Natural Killer Cell Therapies Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Natural Killer Cell Therapies Market Analysis

    • 7.1 North America Natural Killer Cell Therapies Market, by Type

    • 7.2 North America Natural Killer Cell Therapies Market, by Application

    • 7.3 North America Natural Killer Cell Therapies Market Analysis and Forecast, by Country

      • 7.3.1 United States Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Natural Killer Cell Therapies Market Analysis

    • 8.1 Europe Natural Killer Cell Therapies Market, by Type

    • 8.2 Europe Natural Killer Cell Therapies Market, by Application

    • 8.3 Europe Natural Killer Cell Therapies Market Analysis and Forecast, by Country

      • 8.3.1 Germany Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Natural Killer Cell Therapies Market Analysis

    • 9.1 APAC Natural Killer Cell Therapies Market, by Type

    • 9.2 APAC Natural Killer Cell Therapies Market, by Application

    • 9.3 APAC Natural Killer Cell Therapies Market Analysis and Forecast, by Country

      • 9.3.1 China Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Natural Killer Cell Therapies Market Analysis

    • 10.1 Latin America, Middle East and Africa Natural Killer Cell Therapies Market, by Type

    • 10.2 Latin America, Middle East and Africa Natural Killer Cell Therapies Market, by Application

    • 10.3 Latin America, Middle East and Africa Natural Killer Cell Therapies Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Natural Killer Cell Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Natural Killer Cell Therapies Company Profiles

      • 11.1 Kiadis Pharma

        • 11.1.1 Kiadis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Kiadis Pharma Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.1.3 Kiadis Pharma Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Nektar Therapeutics

        • 11.2.1 Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Nektar Therapeutics Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.2.3 Nektar Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 NantWorks

        • 11.3.1 NantWorks Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 NantWorks Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.3.3 NantWorks Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Dragonfly Therapeutics

        • 11.4.1 Dragonfly Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Dragonfly Therapeutics Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.4.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Fate Therapeutics

        • 11.5.1 Fate Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Fate Therapeutics Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.5.3 Fate Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Glycostem

        • 11.6.1 Glycostem Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Glycostem Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.6.3 Glycostem Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Chipscreen Biosciences

        • 11.7.1 Chipscreen Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.7.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Innate

        • 11.8.1 Innate Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Innate Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.8.3 Innate Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Fortress Biotech

        • 11.9.1 Fortress Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Fortress Biotech Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.9.3 Fortress Biotech Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Nkarta Therapeutics

        • 11.10.1 Nkarta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Nkarta Therapeutics Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.10.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Affimed

        • 11.11.1 Affimed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Affimed Natural Killer Cell Therapies Product Profiles, Application and Specification

        • 11.11.3 Affimed Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Natural Killer Cell Therapies Industry Investment Prospect and Risk Assessment

    • 12.1 Natural Killer Cell Therapies Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Natural Killer Cell Therapies Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cell Therapies Production Value and Growth Rate (2017-2028)

    • Figure China Natural Killer Cell Therapies Production Value and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies (2017-2028)

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies (2017-2028)

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Gastrointestinal Diseases (2017-2028)

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cell Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cell Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Natural Killer Cell Therapies Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer Cell Therapies Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer Cell Therapies Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Natural Killer Cell Therapies Market Share, by Manufacturer in 2021

    • Figure Global and China Natural Killer Cell Therapies Market Share, by Manufacturer in 2022

    • Table Global Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Global Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Value, by Type (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Value Share, by Type (2017-2028)

    • Figure Global Natural Killer Cell Therapies Price Trend, by Type (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Value, by Type (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Value Share, by Type (2017-2028)

    • Figure China Natural Killer Cell Therapies Price Trend, by Type (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Global Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Value, by Application (2017-2028)

    • Table Global Natural Killer Cell Therapies Sales Value Share, by Application (2017-2028)

    • Figure Global Natural Killer Cell Therapies Sales Value Share, by Application (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Value, by Application (2017-2028)

    • Table China Natural Killer Cell Therapies Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure North America Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Natural Killer Cell Therapies Production, Import, Consumption and Export (2017-2022)

    • Table North America Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table North America Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure North America Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table North America Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table North America Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure North America Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure United States Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure United States Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Canada Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Table Europe Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table Europe Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Europe Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table Europe Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table Europe Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Europe Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Germany Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure UK Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure UK Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure France Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure France Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Italy Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Spain Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Poland Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Russia Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Table APAC Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table APAC Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure APAC Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table APAC Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table APAC Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure APAC Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Japan Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure India Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure India Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cell Therapies Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer Cell Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer Cell Therapies Sales Value and Growth Rate (2017-2028)

    • Table Kiadis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kiadis Pharma Product Profiles, Application and Specification

    • Table Kiadis Pharma Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nektar Therapeutics Product Profiles, Application and Specification

    • Table Nektar Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NantWorks Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NantWorks Product Profiles, Application and Specification

    • Table NantWorks Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dragonfly Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dragonfly Therapeutics Product Profiles, Application and Specification

    • Table Dragonfly Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fate Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fate Therapeutics Product Profiles, Application and Specification

    • Table Fate Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Glycostem Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glycostem Product Profiles, Application and Specification

    • Table Glycostem Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chipscreen Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chipscreen Biosciences Product Profiles, Application and Specification

    • Table Chipscreen Biosciences Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Innate Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Innate Product Profiles, Application and Specification

    • Table Innate Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fortress Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fortress Biotech Product Profiles, Application and Specification

    • Table Fortress Biotech Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nkarta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nkarta Therapeutics Product Profiles, Application and Specification

    • Table Nkarta Therapeutics Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Affimed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Affimed Product Profiles, Application and Specification

    • Table Affimed Natural Killer Cell Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US